Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons
- PMID: 6145498
- DOI: 10.1016/0006-8993(84)91352-0
Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons
Abstract
Local microiontophoretic administration of cholecystokinin octapeptide (CCK) increased the firing rates of neurons in the dorsomedial nucleus accumbens (NAc), but exerted little to no effect on lateral NAc neurons. This regionally defined CCK-effect corresponds to the topographical distribution of CCK-like immunoreactive nerve terminal fiber networks and CCK receptors within the NAc. The excitatory effects of CCK were selectively antagonized by the CCK antagonist proglumide. Dopamine (DA) decreased the firing of NAc cells and reversed CCK-induced excitation. These results suggest that CCK and DA may interact to influence the activity of neurons within the dorsomedial NAc.
Similar articles
-
Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat.Brain Res. 1985 Jun 3;335(2):337-41. doi: 10.1016/0006-8993(85)90489-5. Brain Res. 1985. PMID: 4005562
-
Effects of long-term haloperidol treatment on the responsiveness of accumbens neurons to cholecystokinin and dopamine: electrophysiological and radioligand binding studies in the rat.J Neurosci. 1990 Feb;10(2):469-78. doi: 10.1523/JNEUROSCI.10-02-00469.1990. J Neurosci. 1990. PMID: 2137531 Free PMC article.
-
In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens.Brain Res. 1986 Nov 5;397(1):200-4. doi: 10.1016/0006-8993(86)91388-0. Brain Res. 1986. PMID: 3801862
-
Cholecystokinin peptides, dopamine and schizophrenia--a review.Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(5-6):515-24. doi: 10.1016/0278-5846(85)90011-9. Prog Neuropsychopharmacol Biol Psychiatry. 1985. PMID: 2868491 Review.
-
Cholecystokinin, dopamine, and schizophrenia: recent progress and current problems.Ann N Y Acad Sci. 1988;537:362-79. doi: 10.1111/j.1749-6632.1988.tb42120.x. Ann N Y Acad Sci. 1988. PMID: 3059932 Review. No abstract available.
Cited by
-
Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models.J Psychiatry Neurosci. 2003 May;28(3):171-81. J Psychiatry Neurosci. 2003. PMID: 12790157 Free PMC article. Review.
-
Cholecystokinin activates CCKB receptors to excite cells and depress EPSCs in the rat rostral nucleus accumbens in vitro.J Physiol. 2004 Feb 15;555(Pt 1):71-84. doi: 10.1113/jphysiol.2003.056739. Epub 2003 Dec 12. J Physiol. 2004. PMID: 14673185 Free PMC article.
-
Devazepide, a CCKA receptor antagonist, impairs the acquisition of conditioned reward and conditioned activity.Psychopharmacology (Berl). 1996 Jan;123(2):131-43. doi: 10.1007/BF02246170. Psychopharmacology (Berl). 1996. PMID: 8741936
-
Involvement of Centrally Projecting Edinger-Westphal Nucleus Neuropeptides in Actions of Addictive Drugs.Brain Sci. 2020 Jan 26;10(2):67. doi: 10.3390/brainsci10020067. Brain Sci. 2020. PMID: 31991932 Free PMC article. Review.
-
Cholecystokinin and tyrosine hydroxylase messenger RNAs in neurons of rat mesencephalon: peptide/monoamine coexistence studies using in situ hybridization combined with immunocytochemistry.Exp Brain Res. 1989;74(1):149-62. doi: 10.1007/BF00248288. Exp Brain Res. 1989. PMID: 2564343
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources